Exclusive plaque psoriasis of the lips: Efficacy of combination therapy of topical tacrolimus, calcipotriol, and betamethasone dipropionate

SKINmed

Volumn 10, Issue 3, 2012, Pages 183-184

  Sehgal, Virendra N ^a   Sehgal, Shruti ^b   Verma, Prashant ^c   Singh, Navjeevan ^c   Rasool, Farhan ^d  

^a Sehgal Nursing Home   (India)

^b Government Engineering Coll   (India)

^c Department of Dermatology and STD ^*  (India)

^d UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE-17,21-DIPROPIONATE; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG COMBINATION; FEMALE; HUMAN; LIP DISEASE; PATHOLOGY; PSORIASIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTIFUNGAL AGENTS; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIP DISEASES; PSORIASIS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84864381527     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-850.
2. Brice DM, Danesh-Meyer MJ. Oral lesions in patients with psoriasis: clinical presentation and management. J Periodontol. 2000;71:1896-1903.
3. Costa SC, Hirota SK, Takahashi MD, et al. Oral lesions in 166 patients with cutaneous psoriasis: a controlled study. Med Oral Patol Oral Cir Bucal. 2009;14:e371-e375.
4. Baumal A, Kantor I, Sachs P. Psoriasis of the lips. Arch Dermatol. 1961;84:185-187.
5. Brenner S, Lipitz R, Illie B, et al. Psoriasis of the lips: the unusual Köbner phenomenon caused by protruding upper teeth. Dermatologica. 1982;164:413-416.
6. Klapholz L, Weinrauch L, Katz M. Perioral psoriasis. Cutis. 1989;43: 157-158.
7. Rahman MA, Fikree M. Perioral psoriasis. J Eur Acad Dermatol Venereol. 2000;14:513-522.
8. Tosti A, Misciali C, Cameli N, et al. Psoriasis of the lips. Eur J Dermatol. 2001;11:589-590.
9. Gül U, Kiliç A, Gönül M, et al. Psoriasis of the lips: an unusual localization. Int J Dermatol. 2006;45:1381-1382.
10. Ersoy-Evans S, Nuralina L, Erkin G, et al. Psoriasis of the lips: a rare entity. J Eur Acad Dermatol Venereol. 2007;21:142-143.
11. Baz K, Yazici AC, Usta A, et al. Isolated lip involvement in psoriasis. Clin Exp Dermatol. 2007;32:578-579.
12. Weathers DR, Baker G, Archard HO, et al. Psoriasiform lesions of the oral mucosa (with emphasis on “ectopic geographic tongue”). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1974;37:872-888.
13. Sehgal VN, Srivastava G, Dogra S. Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I. Skinmed. 2008;7:27-30.
14. O’Neill JL, Feldman SR. Vitamin D analogue-based therapies for psoriasis. Drugs Today. 2010;46:351-360.